Our previous studies have demonstrated that in gastric cancer cells, the binding of c-Met to its ligand HGF leads to a decrease in the levels of phosphorylated Mst1/2, LATS1/2, and YAP/TAZ. This evidence concerns the gene MET and gastric cancer.